Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313235970> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4313235970 endingPage "587" @default.
- W4313235970 startingPage "587" @default.
- W4313235970 abstract "Introduction: In patients with septic shock, vasopressors are required to maintain hemodynamics while patients receive treatment for the underlying etiology. Two vasopressors, norepinephrine and vasopressin, are recommend by guidelines for the management of septic shock in the intensive care unit (ICU). However, limited data exist evaluating outcomes associated with the need for a third vasopressor, as well as risk factors for mortality for patients requiring three vasopressors. Evaluation of these risk factors may help with prognostication and goals of care discussions. Methods: The MIMIC-IV and eICU-CRD databases were queried for patients who were, 1) admitted to any ICU, 2) administered at least three vasopressors for at least two hours, and 3) identified to have sepsis based on the Sepsis-3 criteria. Data collected included demographics such as age, sex, and race as well as objective data such as serum creatinine, lactate, Richmond Agitation Sedation Scale (RASS) score, and Sequential Organ Function Assessment (SOFA) score. A generalized additional model (GAM) was developed to evaluate risk factors for in-hospital mortality in the MIMIC-IV and validated using the eICU-CRD. Results: A total of 1,347 and 2,100 patients met inclusion criteria from the MIMIC and eICU databases, respectively. Septic shock requiring three or more vasopressors was associated with a 57.6% in-hospital mortality rate. The model developed from the MIMIC-IV identified increased age (OR [95% CI]: 3.5 [2.3-5.3]), serum creatinine (1.6 [1.5-1.6]), lactate (2.6 [2.5-2.6]), and SOFA score (1.8 [1.1-2.9]) as risk factors for mortality with statistical significance. This model found consistent results within the eICU-CRD. Conclusions: This study demonstrates that patients started on three or more vasopressors face an exceptionally high mortality burden while identifying indicators for those at the highest risk of mortality. These findings may inform management including end-of-life discussions. Future studies should evaluate differences in mortality outcomes based on timing and choice of third-line vasopressor." @default.
- W4313235970 created "2023-01-06" @default.
- W4313235970 creator A5002390291 @default.
- W4313235970 creator A5003506092 @default.
- W4313235970 creator A5008391714 @default.
- W4313235970 creator A5009182023 @default.
- W4313235970 creator A5017622976 @default.
- W4313235970 creator A5027428989 @default.
- W4313235970 creator A5031401755 @default.
- W4313235970 date "2022-12-15" @default.
- W4313235970 modified "2023-10-16" @default.
- W4313235970 title "1178: INCIDENCE AND RISK OF MORTALITY IN PATIENTS ON THREE VASOPRESSORS FOR MANAGEMENT OF SEPTIC SHOCK" @default.
- W4313235970 doi "https://doi.org/10.1097/01.ccm.0000910448.95597.d2" @default.
- W4313235970 hasPublicationYear "2022" @default.
- W4313235970 type Work @default.
- W4313235970 citedByCount "0" @default.
- W4313235970 crossrefType "journal-article" @default.
- W4313235970 hasAuthorship W4313235970A5002390291 @default.
- W4313235970 hasAuthorship W4313235970A5003506092 @default.
- W4313235970 hasAuthorship W4313235970A5008391714 @default.
- W4313235970 hasAuthorship W4313235970A5009182023 @default.
- W4313235970 hasAuthorship W4313235970A5017622976 @default.
- W4313235970 hasAuthorship W4313235970A5027428989 @default.
- W4313235970 hasAuthorship W4313235970A5031401755 @default.
- W4313235970 hasBestOaLocation W43132359701 @default.
- W4313235970 hasConcept C126322002 @default.
- W4313235970 hasConcept C177713679 @default.
- W4313235970 hasConcept C179755657 @default.
- W4313235970 hasConcept C194828623 @default.
- W4313235970 hasConcept C2776376669 @default.
- W4313235970 hasConcept C2777465075 @default.
- W4313235970 hasConcept C2777628635 @default.
- W4313235970 hasConcept C2778384902 @default.
- W4313235970 hasConcept C2778514916 @default.
- W4313235970 hasConcept C2780306776 @default.
- W4313235970 hasConcept C42219234 @default.
- W4313235970 hasConcept C513476851 @default.
- W4313235970 hasConcept C71924100 @default.
- W4313235970 hasConceptScore W4313235970C126322002 @default.
- W4313235970 hasConceptScore W4313235970C177713679 @default.
- W4313235970 hasConceptScore W4313235970C179755657 @default.
- W4313235970 hasConceptScore W4313235970C194828623 @default.
- W4313235970 hasConceptScore W4313235970C2776376669 @default.
- W4313235970 hasConceptScore W4313235970C2777465075 @default.
- W4313235970 hasConceptScore W4313235970C2777628635 @default.
- W4313235970 hasConceptScore W4313235970C2778384902 @default.
- W4313235970 hasConceptScore W4313235970C2778514916 @default.
- W4313235970 hasConceptScore W4313235970C2780306776 @default.
- W4313235970 hasConceptScore W4313235970C42219234 @default.
- W4313235970 hasConceptScore W4313235970C513476851 @default.
- W4313235970 hasConceptScore W4313235970C71924100 @default.
- W4313235970 hasIssue "1" @default.
- W4313235970 hasLocation W43132359701 @default.
- W4313235970 hasLocation W43132359702 @default.
- W4313235970 hasOpenAccess W4313235970 @default.
- W4313235970 hasPrimaryLocation W43132359701 @default.
- W4313235970 hasRelatedWork W2072467223 @default.
- W4313235970 hasRelatedWork W2096291070 @default.
- W4313235970 hasRelatedWork W2114297303 @default.
- W4313235970 hasRelatedWork W2328839020 @default.
- W4313235970 hasRelatedWork W2728471043 @default.
- W4313235970 hasRelatedWork W2739619278 @default.
- W4313235970 hasRelatedWork W2781723766 @default.
- W4313235970 hasRelatedWork W2920939747 @default.
- W4313235970 hasRelatedWork W2944332401 @default.
- W4313235970 hasRelatedWork W4321636342 @default.
- W4313235970 hasVolume "51" @default.
- W4313235970 isParatext "false" @default.
- W4313235970 isRetracted "false" @default.
- W4313235970 workType "article" @default.